Shazreh Bukhari

ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts

M. Marra, W. Mason, J. Cairncross, 2018, PloS one.

In Vitro Modeling of GBM Initiation using PDGF-AA and P53-Null Neural Progenitors.

S. Weiss, J. Cairncross, E. Holland, 2020, Neuro-oncology.

Beyond Conventional Models: Recreating the Initiation, Evolution, and Genome of GBM

S. Weiss, J. Cairncross, E. Holland, 2019, bioRxiv.

Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype.

M. Geletu, D. Christianson, Abootaleb Sedighi, 2021, Journal of medicinal chemistry.

Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia

T. Aittokallio, S. Mustjoki, S. Timonen, 2021, Journal of medicinal chemistry.

PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia.

Abootaleb Sedighi, P. Gunning, Pimyupa Manaswiyoungkul, 2020, European journal of medicinal chemistry.

Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia.

Abootaleb Sedighi, P. Gunning, Pimyupa Manaswiyoungkul, 2019, ACS medicinal chemistry letters.